Glyburide 5 mg Tablets — Generic For Diabeta — Modavar

Medication Summary

Medication Summary: This section summarizes DailyMed drug label information to make the label easier to understand. It is not a substitute for the official label, pharmacist counseling, prescriber instructions, or medical advice.

Overview

Glyburide tablets, USP are an oral prescription medicine in the sulfonylurea class used along with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus.

The tablets come in 1.25 mg, 2.5 mg, and 5 mg strengths. The 5 mg tablets are green to light green, round, biconvex tablets marked with C11.

The label warns that glyburide can cause severe hypoglycemia (low blood sugar). It also notes that blood sugar should be monitored regularly and that the medicine is not for type 1 diabetes or diabetic ketoacidosis.

Storage Information

Store at 20º to 25ºC (68º to 77ºF); excursions permitted between 15º to 30ºC (59º to 86ºF) [see USP Controlled Room Temperature.

Key Counseling Points

• Use glyburide as an add-on to diet and exercise, not as a substitute for them.
• Take it with breakfast or the first main meal, unless your prescriber instructs otherwise.
• Low blood sugar can occur and may be severe; know the signs and treatment of hypoglycemia.
• Blood sugar should be checked regularly with urine and/or blood glucose testing as directed.
• Glyburide should not be used for type 1 diabetes or diabetic ketoacidosis.
• Tell your healthcare professional about all medicines you take because many drugs can affect glyburide or blood sugar control.
• Use caution with alcohol, prolonged exercise, and missed meals, since these can increase the risk of low blood sugar.
• If you take colesevelam, the label says glyburide tablets should be taken at least 4 hours before it.
• Store the medicine in a tightly closed container with the safety closure as directed on the label.

Helpful Patient Education

Glyburide tablets, USP are a prescription sulfonylurea medicine used with diet and exercise to help improve glycemic control in adults with type 2 diabetes mellitus. This label information describes the 1.25 mg, 2.5 mg, and 5 mg tablets and notes that blood glucose monitoring is an important part of treatment.

Product labeling also highlights key safety points, including the risk of severe hypoglycemia, the need for regular glucose checks, and important drug interaction considerations. Glyburide is not indicated for type 1 diabetes or diabetic ketoacidosis.

Medication Summary last generated: 2026-07-18 02:49:04